Track Coloplast A/S — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Coloplast A/S CLPBY · Stock Open Coloplast A/S in new tab

7.49 USD
P/E
35.90
EPS
0.21
Yield
4.38%
Safety Score
37
P/B
7.91
ROE
20.21
Beta
0.57
Target Price
8.51 USD
Coloplast A/S logo

Coloplast A/S

🧾 Earnings Recap – Q4 2026

Coloplast shares rose 17.5% after earnings, as investors responded to the company’s revised, more cautious long-term ambition alongside plans to invest in Chronic Care and U.S. growth. The reset reflects a more challenging external environment and higher investment, rather than an unchanged growth outlook.

  • Revised its 2030 ambition to 5%–7% annual organic growth and mid-20s EBIT margin in constant currencies; return on invested capital is targeted at around 20% in 2029–30.
  • Management cited price reforms, inflation and the U.S. biologics reimbursement change as pressures behind the revised ambition.
  • Chronic Care, which accounts for more than 75% of group sales, remains the core business. U.S. Chronic Care delivered strong double-digit growth, with ostomy market share around 20%; management aims to sustain around double-digit U.S. Chronic Care momentum in 2026–27.
  • Coloplast plans to increase investment in its innovation pipeline and U.S. commercial opportunities; R&D expenditure rose 13% this year, and more than 10 product launches are expected in 2026–27.
  • The company is focusing Kerecis on inpatient biologics, where growth remains double digit. It expects the focused Wound & Tissue Repair model to deliver around double-digit growth and an EBIT margin above 10%; a DKK 500 million savings program is expected to have about 75% of its impact in 2026–27.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 5, 2027
P/E35.90
EPS0.21
Book Value0.95
Price to Book7.91
Debt/Equity150.56
Growth
Revenue Growth0.07%
Earnings Growth0.36%
Estimates
Forward P/E18.66
Forward EPS0.40
Target Mean Price8.51
Dividend
Dividend Yield4.38%
Annual dividends2.30 USD
Ex-Div. DateDec. 3, 2026
Payout168.61%
5y avg Yield2.25%

DCF valuation

Model fair value for Coloplast A/S (CLPBY)
Result
Sign in to run the valuation for CLPBY.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
4 analysts · consensus Buy · mean target 8.51 USD (low 6.95, high 12.20) · as of 10 Nov 2026
Low 6.95
Mean 8.51
High 12.20
Price 7.49
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Coloplast A/S Logo Coloplast A/S Analysis (CLPBY)

Denmark Health Care Official Website Stock

Is Coloplast A/S a good investment? Coloplast A/S (CLPBY) is currently trading at 7.49 USD. Market analysts have a consensus price target of 8.51 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 35.90. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Coloplast A/S is expected to release its next earnings report on Feb. 5, 2027. The market consensus estimate for Forward EPS is 0.40.

For income investors, Coloplast A/S pays a dividend yield of 4.38%. With a payout ratio of 169%, the dividend appears to be under pressure.

Investor FAQ

Does Coloplast A/S pay a dividend?

Yes, it pays an annual dividend of 2.30 USD (4.38% yield).

What asset class is Coloplast A/S?

Coloplast A/S is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 5, 2027. The company currently has a trailing EPS of 0.21.

Company Profile

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through five segments: Chronic Care, Voice & Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Exchange Ticker
PNK (United States) CLPBY
VIE (Austria) COLO.VI
MEX (Mexico) 0QBON.MX
Trades
Dividend Yield
4.38%
5y avg 2.25%
Annual Dividends
2.30USD
Next Ex. Div Date
Dec. 3, 2026
Payout Ratio
168.61%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
0.08 USD
June 1, 2027 (estimated) 0.0777
▸2026
0.35 USD
Dec. 14, 2026 0.2689
June 1, 2026 0.0777
▸2025
0.36 USD
Dec. 19, 2025 0.2821
May 22, 2025 0.0750
▸2024
0.31 USD
Dec. 20, 2024 0.2390
May 28, 2024 0.0726
▸2023
0.31 USD
Dec. 22, 2023 0.2330
May 30, 2023 0.0727
▸2022
0.28 USD
Dec. 16, 2022 0.2115
May 23, 2022 0.0710
▸2021
0.30 USD
Dec. 17, 2021 0.2130
May 24, 2021 0.0820
▸2020
0.28 USD
Dec. 18, 2020 0.2110
May 26, 2020 0.0730
▸2019
0.25 USD
Dec. 24, 2019 0.1780
May 22, 2019 0.0750
▸2018
0.25 USD
Dec. 24, 2018 0.1677
May 23, 2018 0.0795
▸2017
0.23 USD
Dec. 27, 2017 0.1645
May 24, 2017 0.0657
▸2016
0.20 USD
Dec. 22, 2016 0.1282
May 26, 2016 0.0690
▸2015
0.18 USD
Dec. 28, 2015 0.1174
May 26, 2015 0.0671
▸2014
0.20 USD
Dec. 23, 2014 0.1246
May 29, 2014 0.0737
▸2013
0.13 USD
Dec. 24, 2013 0.1291
Upcoming Dividends
Name Payment Date Status Amount
Coloplast A/S Dec 14, 2026 Upcoming 0.2689 USD
Coloplast A/S Jun 01, 2026 0.077742 USD
Coloplast A/S Dec 19, 2025 0.28212 USD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion